close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Arm Holdings plc - American Depositary Shares (NQ:ARM)

190.53 -9.25 (-4.63%)
Delayed Quote Updated: 4:00 PM EST, Nov 13, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Arm Holdings plc - American Depositary Shares

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
News headline image
Anthropic Is Expected to List on Nov. 19. I'd Rather Own Amazon Stock Than the IPO. ↗
Why pay up for the Claude maker's shares when the e-commerce giant already collects from it? 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Why Arm Holdings Stock Was Pulling Back Today ↗
Arm CEO Rene Haas is reportedly under consideration for the Nvidia job. 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Arm Stock Took a Hit Because Investors Fear Nvidia Might Poach Its CEO. Is It Time to Sell? ↗
Nvidia's board has reportedly approached Rene Haas about replacing Jensen Huang. So investors suddenly have to price in the risk of losing the leader behind its data center push. 
Via The Motley Fool
Topics Initial Public Offering
News headline image
Anthropic’s Valuation Target Has Slipped From $2 Trillion to Under $1.5 Trillion. Here’s Why ↗
Anthropic scaled back its IPO valuation target. Should that worry investors? 
Via The Motley Fool
Topics Artificial Intelligence Initial Public Offering
News headline image
Who Will Replace Jensen Huang? Here's What Prediction Markets Think. ↗
Jensen Huang has resigned as CEO of Nvidia. 
Via The Motley Fool
Topics Artificial Intelligence Supply Chain
News headline image
Imunon (IMNN) Q3 2026 Earnings Call Transcript ↗
Enrollment is ahead of plan in its pivotal ovarian cancer trial as cash tightens. 
Via The Motley Fool
Topics Earnings
News headline image
3 Unstoppable Dow Stocks to Buy in November and Hold for the Next Decade ↗
Three Dow giants pair market dominance with the financial strength to keep growing for the next decade. 
Via The Motley Fool
Topics Artificial Intelligence Stocks
News headline image
Here's My Top Long-Term Compounder to Buy Right Now ↗
Brookfield's latest results are a big reason I keep adding to my position. 
Via The Motley Fool
News headline image
What’s Nvidia Worth Without Jensen Huang? 1 Indicator I'm Watching Now ↗
Jensen Huang has resigned as Nvidia CEO. What does it mean for Nvidia stock? 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Why Micron Stock Dropped on Thursday ↗
Nvidia just lost its CEO -- so why is Micron stock down? 
Via The Motley Fool
Topics Artificial Intelligence
Stock Market Today: CoreWeave (CRWV) Reignites the AI Trade, Then Nvidia’s (NVDA) Boardroom Takes Over the Story ↗
Via Chartmill
Topics Artificial Intelligence
News headline image
GE Vernova Fell 25% on Data Center Fears. Only About 20% of Its Gas Turbine Customers Are Data Centers. Time to Buy? ↗
Investors may be viewing this company's future as being more dependent on the AI industry than it actually is. 
Via The Motley Fool
Topics Artificial Intelligence Energy
News headline image
Chip Stocks Rally After Slide. These Names Are Leading The Charge Higher. ↗
Chip stocks broadly rallied on Wednesday as investors went bargain-hunting. The Philadelphia semiconductor index, or SOX, surged. 
Via Investor's Business Daily
News headline image
SNDL: 3 Key Takeaways for Long-Term Investors ↗
A regulatory settlement in Ontario will shrink reported revenue by CAD 105 million while barely denting operating profit, exposing the real earnings power underneath. 
Via The Motley Fool
Topics Cannabis Earnings
News headline image
2 Stocks I'd Buy Right Now and Hold Through 2035 ↗
Both of these companies are spending heavily today to build the next decade's growth. 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
The AI Debt Bill Is Coming Due, But Biotech Has Revenue to Show for the Boom ↗
AI infrastructure is being funded with debt and stock sales while biotech companies applying AI are booking revenue, led by Tempus AI, Recursion and iShares Biotechnology 
Via MarketBeat
Topics Artificial Intelligence Bankruptcy
News headline image
Resideo: 3 Key Takeaways for Long-Term Investors ↗
Management is betting on branded hardware over third-party OEM work, a shift that could reshape margins for years to come. 
Via The Motley Fool
Topics Earnings Economy
News headline image
Is KKR a Buy After Its Latest Earnings Report? ↗
The financial company posted an impressive jump in adjusted earnings. 
Via The Motley Fool
News headline image
Definium Therapeutics Eyes FDA Filing for LSD Treatment After Three Positive Phase 3 Studies ↗
Definium Therapeutics (NASDAQ:DFTX) plans to submit a new drug application to the U.S. Food and Drug Administration for its LSD formulation DT120 in the first half of next year, following positive... 
Via MarketBeat
News headline image
Cellectar (CLRB) Q3 2026 Earnings Call Transcript ↗
Management details the phase III trial and U.S. approval timeline for its lead asset. 
Via The Motley Fool
Topics Earnings
News headline image
When Independence Is Everything: Simone’s Journey of Finding Accessible, Minimally Invasive Carpal Tunnel Syndrome Relief
(BPT) - For Simone Duven, using her hands isn't optional. Paralyzed from the waist down, she relies on them to move her wheelchair, transfer in and out of bed and shift her weight to help prevent... 
Via Brandpoint
News headline image
As Democrats Take Over Congress, Is Palantir Stock at Risk? ↗
The AI data analytics stock is now trading 19% below its October high. 
Via The Motley Fool
Topics Artificial Intelligence Government
News headline image
What Myomo (MYO) Said on Its Q3 Earnings Call ↗
Myomo (NYSEAMERICAN:MYO) reported record third-quarter revenue of $12.3 million, up 22% from a year earlier, and narrowed its full-year revenue guidance as referrals and higher sales of its powered arm... 
Via MarketBeat
Topics Earnings
News headline image
CAMP4 Therapeutics Targets First SYNGAP1 Data in 2028 as Patient Dosing Nears ↗
CAMP4 Therapeutics (NASDAQ:CAMP) expects initial data from its SYNGAP1 clinical program in the first half of 2028, as the company prepares to begin dosing patients with a treatment designed to increase... 
Via MarketBeat
News headline image
Atea Pharma (AVIR) Q3 2026 Earnings Call Transcript ↗
Phase 3 hepatitis C data met its endpoints and funding now extends into mid-2028. 
Via The Motley Fool
Topics Earnings
News headline image
Ocular Tx (OCUL) Q3 2026 Earnings Call Transcript ↗
Management outlined AXPAXLI's regulatory path and late-stage trial updates. 
Via The Motley Fool
Topics Earnings
News headline image
Is Arm Stock a Buy on the Dip as Agentic AI Opportunity Emerges? ↗
Arm shares sank despite an upbeat outlook for the company's new CPU business. 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Arm and Qualcomm Lead Mobile Chip Design. 1 Stock Is the Better Buy. ↗
Both of these stocks saw their shares in free fall following earnings. 
Via The Motley Fool
Topics Intellectual Property Lawsuit Stocks
News headline image
Bloom Energy Stock Fell 16% on the Same Day 2 Giant Data Center Deals Named It. Is It a Buy? ↗
Only one of the two deals is new business. Is the stock's drop an opening? 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Not Bloom Energy. Not Vistra. This AI Power Stock Just Posted a 96% Jump in Orders. ↗
The impending change in the political backdrop isn't apt to actually affect the growing demand for its equipment, either. 
Via The Motley Fool
Topics Artificial Intelligence Energy
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at /week.